RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS
DRGS
DRGS was delisted on the 6th of July, 2015.
4 hedge funds and large institutions have $463K invested in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
7,620% more capital invested
Capital invested by funds: $6K → $463K (+$457K)
300% more funds holding
Funds holding: 1 → 4 (+3)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$363K |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$72.1K |
| 3 |
AIG
American International Group
New York
|
+$9.88K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Goldman Sachs
New York
| $374K | +$363K | +7,350 | New |
|
|
U
2
UBS
Zurich,
Switzerland
| $74K | +$72.1K | +1,460 | New |
|
|
AIG
3
American International Group
New York
| $10.2K | +$9.88K | +200 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $5K | +$5.14K | +104 | New |
|
|
5
Citigroup
New York
| – | -$6K | -125 | Closed |
|
DRGS Hedge Fund Activity: Q3 2014 in Review
4 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) for Q3 2014, worth a combined $463K — up 7,620% from $6K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new DRGS positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $363K. The largest seller was Citigroup, exiting entirely with an estimated $6K sold.
- 4 institutional investors held RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) as of Q3 2014, up from 1 in Q2 2014.
- Funds reported $463K of RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS stock for Q3 2014, up 7,620% quarter-over-quarter.
- 4 funds opened new RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS positions in Q3 2014 and 1 closed out, a net change of +3 holders.
- The largest RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS buyer in Q3 2014 was Goldman Sachs, an estimated $363K added.
- The largest RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS seller in Q3 2014 was Citigroup, an estimated $6K sold.
Based on aggregated 13F filings for Q3 2014.